These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 11313996
1. Mechanism of repression of squamous differentiation marker, SPRR1B, in malignant bronchial epithelial cells: role of critical TRE-sites and its transacting factors. Patterson T, Vuong H, Liaw YS, Wu R, Kalvakolanu DV, Reddy SP. Oncogene; 2001 Feb 01; 20(5):634-44. PubMed ID: 11313996 [Abstract] [Full Text] [Related]
4. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es). Farina AR, Cappabianca L, Mackay AR, Tiberio A, Tacconelli A, Tessitore A, Frati L, Martinotti S, Gulino A. Cell Growth Differ; 1997 Jul 01; 8(7):789-800. PubMed ID: 9218873 [Abstract] [Full Text] [Related]
6. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins. Risse-Hackl G, Adamkiewicz J, Wimmel A, Schuermann M. Oncogene; 1998 Jun 11; 16(23):3057-68. PubMed ID: 9662339 [Abstract] [Full Text] [Related]
7. Identification of a novel SP3 binding site in the promoter of human IGFBP4 gene: role of SP3 and AP-1 in regulating promoter activity in CaCo2 cells. Shen Q, Singh P. Oncogene; 2004 Apr 01; 23(14):2454-64. PubMed ID: 14767471 [Abstract] [Full Text] [Related]
8. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins. Bahr MJ, Vincent KJ, Arthur MJ, Fowler AV, Smart DE, Wright MC, Clark IM, Benyon RC, Iredale JP, Mann DA. Hepatology; 1999 Mar 01; 29(3):839-48. PubMed ID: 10051488 [Abstract] [Full Text] [Related]
10. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers. Suzukawa K, Colburn NH. Oncogene; 2002 Mar 28; 21(14):2181-90. PubMed ID: 11948401 [Abstract] [Full Text] [Related]
12. fra-2 promoter can respond to serum-stimulation through AP-1 complexes. Sonobe MH, Yoshida T, Murakami M, Kameda T, Iba H. Oncogene; 1995 Feb 16; 10(4):689-96. PubMed ID: 7862446 [Abstract] [Full Text] [Related]
13. Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1. Wang CC, Tsai MF, Dai TH, Hong TM, Chan WK, Chen JJ, Yang PC. Cancer Res; 2007 May 15; 67(10):4816-26. PubMed ID: 17510411 [Abstract] [Full Text] [Related]
14. Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells. Briggs J, Chamboredon S, Castellazzi M, Kerry JA, Bos TJ. Oncogene; 2002 Oct 10; 21(46):7077-91. PubMed ID: 12370830 [Abstract] [Full Text] [Related]
16. Mitogen regulated induction of FRA-1 proto-oncogene is controlled by the transcription factors binding to both serum and TPA response elements. Adiseshaiah P, Peddakama S, Zhang Q, Kalvakolanu DV, Reddy SP. Oncogene; 2005 Jun 16; 24(26):4193-205. PubMed ID: 15806162 [Abstract] [Full Text] [Related]
19. Hepatic stellate cells lack AP-1 responsiveness to electrophiles and phorbol 12-myristate-13-acetate. Reichard JF, Petersen DR. Biochem Biophys Res Commun; 2004 Sep 24; 322(3):842-53. PubMed ID: 15336540 [Abstract] [Full Text] [Related]
20. MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability. Cuevas BD, Uhlik MT, Garrington TP, Johnson GL. Oncogene; 2005 Jan 27; 24(5):801-9. PubMed ID: 15558021 [Abstract] [Full Text] [Related] Page: [Next] [New Search]